Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB for Mantle cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 3,940 adverse event reports in the FDA FAERS database where RITUXIMAB was used for Mantle cell lymphoma.

Most Reported Side Effects for RITUXIMAB

Side Effect Reports % Deaths Hosp.
Off label use 39,751 22.3% 6,335 11,201
Drug ineffective 32,186 18.0% 3,169 7,462
Rheumatoid arthritis 19,850 11.1% 2,167 5,477
Pain 16,675 9.3% 2,124 5,092
Fatigue 15,602 8.7% 2,477 5,183
Arthralgia 12,529 7.0% 1,864 4,945
Rash 12,102 6.8% 2,343 4,411
Drug intolerance 11,876 6.7% 1,703 3,314
Infusion related reaction 11,871 6.7% 2,239 4,458
Joint swelling 11,170 6.3% 2,145 4,040
Pneumonia 11,068 6.2% 3,093 5,544
Contraindicated product administered 10,479 5.9% 1,426 2,981
Nausea 10,250 5.7% 1,642 4,430
Alopecia 10,119 5.7% 1,721 3,105
Pyrexia 10,061 5.6% 2,054 5,833

Other Indications for RITUXIMAB

Rheumatoid arthritis (40,017) Product used for unknown indication (24,023) Diffuse large b-cell lymphoma (22,275) B-cell lymphoma (7,811) Chronic lymphocytic leukaemia (7,231) Non-hodgkin's lymphoma (5,959) Follicular lymphoma (3,294) Granulomatosis with polyangiitis (3,222) Lymphoma (3,142) Systemic lupus erythematosus (2,659)

Other Drugs Used for Mantle cell lymphoma

IBRUTINIB (6,306) LENALIDOMIDE (2,989) CYCLOPHOSPHAMIDE (1,815) DOXORUBICIN (1,396) VENETOCLAX (1,367) VINCRISTINE (1,361) BENDAMUSTINE (1,227) CYTARABINE (1,174) DEXAMETHASONE (949) PREDNISONE (852)

Related Pages

RITUXIMAB Full Profile All Mantle cell lymphoma Drugs RITUXIMAB Demographics RITUXIMAB Timeline